Biogen LUNSUMIO — Sales trigger gross sales threshold remained flat by 0.0% to $350.00M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Exceeding this threshold indicates successful product scaling and typically triggers favorable financial adjustments for the parties involved.
This is a defined gross sales level that, when exceeded, triggers a specific contractual event or adjustment in the Luns...
Typical in commercialization agreements where profit-sharing percentages scale with product revenue.
biib_segment_lunsumio_sales_trigger_gross_sales_threshold| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $350.00M | $350.00M |
| QoQ Change | — | +0.0% |
| YoY Change | — | +0.0% |